Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus
- PMID: 12821453
- PMCID: PMC161835
- DOI: 10.1128/AAC.47.7.2100-2107.2003
Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus
Abstract
The influences of test variables on the outcome of susceptibility testing with caspofungin were tested with isolates of Candida spp. and Aspergillus fumigatus. Among six growth conditions tested with a range of inoculum sizes, the highest control growth yields were obtained in Sabouraud broth for all fungi, followed by RPMI 1640 (pH 7) for Candida spp. and antibiotic medium 3 (AM3) for A. fumigatus. RPMI 1640 gave unacceptably low growth yields with A. fumigatus. The caspofungin MICs under these various conditions ranged over more than 4 twofold dilutions for 7 of 16 fungi tested when a 50% inhibition (50% inhibitory concentration [IC(50)]) endpoint was used and for 12 of 16 fungi tested when an 80% inhibition (IC(80)) endpoint was used. A multifactorial design to study the influences of six test variables on control growth and the MIC showed that, for 14 isolates of Candida spp., the glucose concentration and the medium composition were the most common factors significantly influencing both control growth yields and the MIC. For eight A. fumigatus isolates, incubation time (24 versus 48 h) and temperature (30 versus 35 degrees C) significantly affected control optical density (OD) values, while growth medium (AM3 versus Sabouraud broth) was the most common process variable affecting the MICs. Tests with AM3 from three suppliers showed significant variations in control OD values related to supplier, but IC(50)s fell within a 2- or 3-dilution range for 19 (86%) of the 22 isolates tested. We recommend that, at present, AM3 is superior to RPMI 1640 for testing of the susceptibilities of both yeasts and filamentous fungi to caspofungin and that a minimum incubation time of 48 h is necessary to test A. fumigatus adequately.
Similar articles
-
Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).J Clin Microbiol. 2003 Jan;41(1):403-9. doi: 10.1128/JCM.41.1.403-409.2003. J Clin Microbiol. 2003. PMID: 12517880 Free PMC article.
-
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.J Clin Microbiol. 2004 Aug;42(8):3475-82. doi: 10.1128/JCM.42.8.3475-3482.2004. J Clin Microbiol. 2004. PMID: 15297486 Free PMC article.
-
Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.J Clin Microbiol. 2001 Dec;39(12):4387-9. doi: 10.1128/JCM.39.12.4387-4389.2001. J Clin Microbiol. 2001. PMID: 11724849 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin.Med Mycol. 2005 May;43 Suppl 1:S299-305. doi: 10.1080/13693780400029023. Med Mycol. 2005. PMID: 16110824 Review.
Cited by
-
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.J Clin Microbiol. 2004 Jul;42(7):3117-9. doi: 10.1128/JCM.42.7.3117-3119.2004. J Clin Microbiol. 2004. PMID: 15243069 Free PMC article.
-
In Vitro Activity of Caspofungin Against Fluconazole-Resistant Candida Species Isolated From Clinical Samples in Iran.Jundishapur J Microbiol. 2015 Jun 27;8(6):e18353. doi: 10.5812/jjm.18353v2. eCollection 2015 Jun. Jundishapur J Microbiol. 2015. PMID: 26322202 Free PMC article.
-
Effect of reduced oxygen on the antifungal susceptibility of clinically relevant aspergilli.Antimicrob Agents Chemother. 2015 Mar;59(3):1806-10. doi: 10.1128/AAC.04204-14. Epub 2014 Dec 29. Antimicrob Agents Chemother. 2015. PMID: 25547350 Free PMC article.
-
Aspergillus ustus infections among transplant recipients.Emerg Infect Dis. 2006 Mar;12(3):403-8. doi: 10.3201/eid1203.050670. Emerg Infect Dis. 2006. PMID: 16704776 Free PMC article.
-
Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006.Antimicrob Agents Chemother. 2008 Feb;52(2):778-81. doi: 10.1128/AAC.01140-07. Epub 2007 Dec 10. Antimicrob Agents Chemother. 2008. PMID: 18070978 Free PMC article.
References
-
- Barchiesi, F., A. M. Schimizzi, A. W. Fothergill, G. Scalise, and M. G. Rinaldi. 1999. In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species. Eur. J. Clin. Microbiol. Infect. Dis. 18:302-304. - PubMed
-
- Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous